RU2286784C2 - Таблетка, содержащая цетиризин и псевдоэфедрин - Google Patents

Таблетка, содержащая цетиризин и псевдоэфедрин Download PDF

Info

Publication number
RU2286784C2
RU2286784C2 RU2004101231/15A RU2004101231A RU2286784C2 RU 2286784 C2 RU2286784 C2 RU 2286784C2 RU 2004101231/15 A RU2004101231/15 A RU 2004101231/15A RU 2004101231 A RU2004101231 A RU 2004101231A RU 2286784 C2 RU2286784 C2 RU 2286784C2
Authority
RU
Russia
Prior art keywords
pseudoephedrine
cetirizine
tablet according
segment
tablet
Prior art date
Application number
RU2004101231/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2004101231A (ru
Inventor
Доменико ФАНАРА (BE)
Доменико Фанара
Антони ГИШО (BE)
Антони ГИШО
Моник БЕРВАЕ (BE)
Моник БЕРВАЕ
Мишель ДЕЛЕЕР (BE)
Мишель ДЕЛЕЕР
Original Assignee
ЮСиБи ФАРШИМ С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЮСиБи ФАРШИМ С.А. filed Critical ЮСиБи ФАРШИМ С.А.
Publication of RU2004101231A publication Critical patent/RU2004101231A/ru
Application granted granted Critical
Publication of RU2286784C2 publication Critical patent/RU2286784C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
RU2004101231/15A 2001-06-28 2002-06-10 Таблетка, содержащая цетиризин и псевдоэфедрин RU2286784C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30125001P 2001-06-28 2001-06-28
EP01115807 2001-06-28
EP01115807.8 2001-06-28
US60/301,250 2001-06-28

Publications (2)

Publication Number Publication Date
RU2004101231A RU2004101231A (ru) 2005-04-20
RU2286784C2 true RU2286784C2 (ru) 2006-11-10

Family

ID=56290291

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004101231/15A RU2286784C2 (ru) 2001-06-28 2002-06-10 Таблетка, содержащая цетиризин и псевдоэфедрин

Country Status (22)

Country Link
EP (1) EP1404304B1 (enExample)
JP (1) JP4041460B2 (enExample)
KR (1) KR100926410B1 (enExample)
CN (1) CN100490809C (enExample)
AT (1) ATE432068T1 (enExample)
AU (1) AU2002345024B2 (enExample)
BR (1) BR0210650A (enExample)
CA (1) CA2451519C (enExample)
CZ (1) CZ20033454A3 (enExample)
DK (1) DK1404304T3 (enExample)
EE (1) EE05357B1 (enExample)
ES (1) ES2324769T3 (enExample)
HU (1) HU229803B1 (enExample)
MX (1) MXPA03010430A (enExample)
NZ (1) NZ530289A (enExample)
PL (1) PL206069B1 (enExample)
PT (1) PT1404304E (enExample)
RO (1) RO122476B1 (enExample)
RU (1) RU2286784C2 (enExample)
SI (1) SI1404304T1 (enExample)
SK (1) SK287645B6 (enExample)
WO (1) WO2003002098A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2446796C2 (ru) * 2006-12-26 2012-04-10 Фармасайкликс, Инк. Способ использования ингибиторов гистондеацетилазы и мониторинга биомаркеров в комбинированной терапии
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
US9492423B2 (en) 2011-09-13 2016-11-15 Pharmacyclics Llc Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014867B2 (en) * 2001-06-28 2006-03-21 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
US20100172984A1 (en) * 2006-06-06 2010-07-08 Bijay Kumar Padhi tablet dosage form comprising cetirizine and pseudoephedrine
KR101193495B1 (ko) 2010-02-01 2012-10-23 한미사이언스 주식회사 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물
CA2802853C (en) 2010-06-16 2016-07-26 Bruce Chandler May Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation
CN102302497A (zh) * 2011-05-18 2012-01-04 天圣制药集团股份有限公司 一种治疗过敏性鼻炎的制剂及其制备方法
KR20130009553A (ko) 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
KR101372324B1 (ko) * 2012-02-09 2014-03-13 동국대학교 경주캠퍼스 산학협력단 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물
WO2014164299A1 (en) 2013-03-13 2014-10-09 Inflammatory Response Research, Inc. Use of levocetirizine and montelukast in the treatment of autoimmune disorders
EP3308835B1 (en) 2013-03-13 2020-01-01 Inflammatory Response Research, Inc. Use of levocetirizine and montelukast in the treatment of traumatic injury
CN105263579B (zh) 2013-03-13 2020-01-10 炎症反应研究公司 左西替利嗪和孟鲁司特在治疗血管炎中的用途
JP2017526728A (ja) 2014-09-15 2017-09-14 インフラマトリー・レスポンス・リサーチ・インコーポレイテッド 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト
WO2016140630A1 (en) 2015-03-05 2016-09-09 PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. An effervescent composition comprising levocetirizine and pseudoephedrine
KR20220137065A (ko) * 2020-02-03 2022-10-11 존슨 앤드 존슨 컨수머 인코포레이티드 세티리진을 포함하는 단일층 츄어블 정제

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2311940A (en) * 1996-04-08 1997-10-15 Ucb Sa Pharmaceutical compositions for the treatment of rhinitis
RU95121769A (ru) * 1993-04-30 1998-02-10 Зе Проктер энд Гэмбл Компани Фармацевтические композиции с покрытием и способы лечения с их помощью респеративных заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU95121769A (ru) * 1993-04-30 1998-02-10 Зе Проктер энд Гэмбл Компани Фармацевтические композиции с покрытием и способы лечения с их помощью респеративных заболеваний
GB2311940A (en) * 1996-04-08 1997-10-15 Ucb Sa Pharmaceutical compositions for the treatment of rhinitis

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2446796C2 (ru) * 2006-12-26 2012-04-10 Фармасайкликс, Инк. Способ использования ингибиторов гистондеацетилазы и мониторинга биомаркеров в комбинированной терапии
US9408816B2 (en) 2006-12-26 2016-08-09 Pharmacyclics Llc Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US9132246B2 (en) 2007-10-09 2015-09-15 Microdose Therapeutx, Inc. Inhalation device
US9539400B2 (en) 2007-10-09 2017-01-10 Microdose Therapeutx, Inc. Inhalation device
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
US9974909B2 (en) 2010-01-05 2018-05-22 Microdose Therapeutx, Inc. Inhalation device and method
US10434267B2 (en) 2010-01-05 2019-10-08 Microdose Therapeutx, Inc. Inhalation device and method
US9492423B2 (en) 2011-09-13 2016-11-15 Pharmacyclics Llc Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof

Also Published As

Publication number Publication date
CN1520285A (zh) 2004-08-11
HU229803B1 (en) 2014-07-28
PL206069B1 (pl) 2010-06-30
NZ530289A (en) 2004-11-26
ES2324769T3 (es) 2009-08-14
JP4041460B2 (ja) 2008-01-30
CZ20033454A3 (cs) 2004-08-18
EP1404304B1 (en) 2009-05-27
DK1404304T3 (da) 2009-07-13
KR100926410B1 (ko) 2009-11-12
ATE432068T1 (de) 2009-06-15
JP2004536829A (ja) 2004-12-09
WO2003002098A1 (en) 2003-01-09
KR20040007756A (ko) 2004-01-24
RO122476B1 (ro) 2009-07-30
CN100490809C (zh) 2009-05-27
PT1404304E (pt) 2009-06-26
HUP0400386A2 (hu) 2004-08-30
SK287645B6 (sk) 2011-05-06
CA2451519C (en) 2007-11-06
PL366800A1 (en) 2005-02-07
RU2004101231A (ru) 2005-04-20
BR0210650A (pt) 2004-10-05
AU2002345024B2 (en) 2006-09-07
HUP0400386A3 (en) 2006-02-28
CA2451519A1 (en) 2003-01-09
SI1404304T1 (sl) 2009-10-31
EP1404304A1 (en) 2004-04-07
EE05357B1 (et) 2010-12-15
EE200400005A (et) 2004-02-16
SK15502003A3 (sk) 2004-05-04
MXPA03010430A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
RU2286784C2 (ru) Таблетка, содержащая цетиризин и псевдоэфедрин
JP2007176958A (ja) セチリジン及びプソイドエフェドリンを含む錠剤
AU2002345024A1 (en) Tablet comprising cetirizine and pseudoephedrine
AU2011339150B2 (en) Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
US20080206331A1 (en) Tablet comprising efletirizine and pseudoephedrine
EP1465607B1 (fr) Compositions pharmaceutiques a liberation modifiee
US8263124B2 (en) Anthistamine-decongestant pharmaceutical compositions
HK1064596B (en) Tablet comprising cetirizine and pseudoephedrine
TWI243061B (en) Tablet comprising cetirizine and pseudoephedrine